Zogenix Stock Price

-0.12 (-0.63%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Zogenix Inc ZGNX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.12 -0.63% 18.80 20:00:00
Open Price Low Price High Price Close Price Prev Close
18.74 18.33 18.90 18.80 18.92
Bid Price Ask Price Spread News
18.30 24.00 5.70 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,807 231,131 $ 18.65 $ 4,311,018 998,357 17.2033 - 33.85
Last Trade Time Type Quantity Stock Price Currency
16:35:49 58 $ 18.80 USD

Zogenix Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.05B 55.67M 55.39M $ 3.65M $ - -9.67 -5.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Zogenix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZGNX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.7720.0518.3319.28414,7650.030.16%
1 Month20.00520.8018.0819.28722,580-1.21-6.02%
3 Months19.8623.6918.0820.74770,859-1.06-5.34%
6 Months20.3623.6917.8020.60842,758-1.56-7.66%
1 Year26.6133.8517.203322.65972,006-7.81-29.35%
3 Years40.8062.7516.6533.43770,695-22.00-53.92%
5 Years10.8862.757.3331.85649,6377.9272.79%

Zogenix Description

Zogenix Inc is engaged in developing and commercializing therapeutic solutions for people living with serious and life-threatening rare CNS disorders and medical conditions. Its product candidate includes ZX008, low-dose fenfluramine for the treatment of Dravet syndrome, LGS, and potentially other rare and catastrophic epilepsy disorders.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.